Igor Novitzky‐Basso

University Health Network — Canada

Medicine · Health Sciences

18h-index2.2kcitations164works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(83), Acute Myeloid Leukemia Research(41), Acute Lymphoblastic Leukemia research(28), Chronic Myeloid Leukemia Treatments(28), Renal Transplantation Outcomes and Treatments(21)

Publications161 total

Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia.
PubMed·2026
Validation of the Refined ELN 2022 AML Risk Stratification Incorporating an Adverse-Plus Category and Impact on Allogeneic Transplant Outcome
Transplantation and Cellular Therapy·2026
The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes
Cancers·2026Open Access
A small step yet one giant leap for cGVHD biomarkers
Blood·2026Open Access
Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2026
Eltrombopag in Treating Post‐Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
European Journal Of Haematology·2025Open Access
Impact of graft‐versus‐host disease prophylaxis strategies on <scp>GvHD</scp> ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis
British Journal of Haematology·2025
Comparison of alemtuzumab and ATG-based conditioning in adult recipients of allogeneic hematopoietic cell transplantation (HCT) for severe aplastic anemia: A retrospective study
Blood·2025Open Access
Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation
Blood·2025
Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)
Blood·2025Open Access
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival
Annals of Hematology·2025· 1 citedOpen Access
Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2025
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study
Clinical Microbiology and Infection·2025· 2 cited
Don't fly and freeze: impact of ex vivo time, cell density and cryopreservation on allogeneic stem cell grafts
Cytotherapy·2025
Can we move beyond myeloablative conditioning ( <scp>MAC</scp> )? A comparison of <scp>MAC</scp> versus reduced intensity conditioning ( <scp>RIC</scp> ) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using <scp>ATG</scp> ‐ <scp>PTCy</scp> ‐ <scp>CSA</scp> for <scp>GVHD</scp> prophylaxis
British Journal of Haematology·2025Open Access
Erythroid Atypical Chemokine Receptor 1 Deficiency Aggravates Immune-Mediated Kidney Disease
Journal of the American Society of Nephrology·2025Open Access
Endothelial activation and stress index ( <scp>EASIX</scp> ) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment
British Journal of Haematology·2025Open Access
A decade of experience using <scp>ATG</scp> and <scp>PTCy</scp> for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation
British Journal of Haematology·2025· 3 cited
Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation
British Journal of Haematology·2025· 2 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Jonas Mattsson(30), Dennis Dong Hwan Kim(29), Arjun Law(27), Rajat Kumar(27), Jeffrey H. Lipton(25), Ivan Pašić(24), Fotios V. Michelis(24), Auro Viswabandya(24), Wilson Lam(21), Armin Gerbitz(21), Carol Chen(12), Mats Remberger(9), Tommy Alfaro Moya(9), Eshetu G. Atenafu(8), María Queralt Salas(7), Eshrak Al‐Shaibani(6), Anargyros Xenocostas(6), Tracy Stockley(6), Abel Santos Carreira(5), Kristjan Paulson(5)